Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 8/10

vs
industry
vs
history
Cash to Debt 0.93
MDSO's Cash to Debt is ranked lower than
53% of the 1702 Companies
in the Global Software - Application industry.

( Industry Median: 20.91 vs. MDSO: 0.93 )
MDSO' s 10-Year Cash to Debt Range
Min: 0.4   Max: No Debt
Current: 0.93

Equity to Asset 0.41
MDSO's Equity to Asset is ranked lower than
53% of the 1664 Companies
in the Global Software - Application industry.

( Industry Median: 0.60 vs. MDSO: 0.41 )
MDSO' s 10-Year Equity to Asset Range
Min: -1.75   Max: 0.67
Current: 0.41

-1.75
0.67
Interest Coverage 4.03
MDSO's Interest Coverage is ranked lower than
62% of the 1085 Companies
in the Global Software - Application industry.

( Industry Median: 434.43 vs. MDSO: 4.03 )
MDSO' s 10-Year Interest Coverage Range
Min: 4.03   Max: 9999.99
Current: 4.03

4.03
9999.99
F-Score: 6
Z-Score: 5.38
M-Score: -1.77
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry
vs
history
Operating margin (%) 8.63
MDSO's Operating margin (%) is ranked higher than
78% of the 1673 Companies
in the Global Software - Application industry.

( Industry Median: 5.43 vs. MDSO: 8.63 )
MDSO' s 10-Year Operating margin (%) Range
Min: -36.17   Max: 14
Current: 8.63

-36.17
14
Net-margin (%) 6.02
MDSO's Net-margin (%) is ranked higher than
75% of the 1672 Companies
in the Global Software - Application industry.

( Industry Median: 3.67 vs. MDSO: 6.02 )
MDSO' s 10-Year Net-margin (%) Range
Min: -52.41   Max: 21.36
Current: 6.02

-52.41
21.36
ROE (%) 7.38
MDSO's ROE (%) is ranked higher than
69% of the 1630 Companies
in the Global Software - Application industry.

( Industry Median: 6.75 vs. MDSO: 7.38 )
MDSO' s 10-Year ROE (%) Range
Min: 7.38   Max: 44.63
Current: 7.38

7.38
44.63
ROA (%) 2.91
MDSO's ROA (%) is ranked higher than
65% of the 1690 Companies
in the Global Software - Application industry.

( Industry Median: 3.50 vs. MDSO: 2.91 )
MDSO' s 10-Year ROA (%) Range
Min: -53.2   Max: 20.75
Current: 2.91

-53.2
20.75
ROC (Joel Greenblatt) (%) 57.94
MDSO's ROC (Joel Greenblatt) (%) is ranked higher than
79% of the 1673 Companies
in the Global Software - Application industry.

( Industry Median: 30.08 vs. MDSO: 57.94 )
MDSO' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -162.03   Max: 266.31
Current: 57.94

-162.03
266.31
Revenue Growth (%) 14.00
MDSO's Revenue Growth (%) is ranked higher than
84% of the 1401 Companies
in the Global Software - Application industry.

( Industry Median: 5.80 vs. MDSO: 14.00 )
MDSO' s 10-Year Revenue Growth (%) Range
Min: -21.7   Max: 14
Current: 14

-21.7
14
EBITDA Growth (%) -5.60
MDSO's EBITDA Growth (%) is ranked higher than
59% of the 1136 Companies
in the Global Software - Application industry.

( Industry Median: 6.90 vs. MDSO: -5.60 )
MDSO' s 10-Year EBITDA Growth (%) Range
Min: 0   Max: 14.7
Current: -5.6

0
14.7
» MDSO's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q3 2013

MDSO Guru Trades in Q3 2013

Mariko Gordon 3,640 sh (New)
Steven Cohen 89,762 sh (New)
Chuck Royce 20,000 sh (unchged)
Jim Simons Sold Out
» More
Q4 2013

MDSO Guru Trades in Q4 2013

Columbia Wanger 443,000 sh (New)
Jim Simons 60,094 sh (New)
Ron Baron 121,000 sh (New)
Chuck Royce 41,700 sh (+4.25%)
Mariko Gordon Sold Out
Steven Cohen Sold Out
» More
Q1 2014

MDSO Guru Trades in Q1 2014

Steven Cohen 102,820 sh (New)
Ron Baron 518,040 sh (+328.13%)
Columbia Wanger 662,500 sh (+49.55%)
Jim Simons 80,669 sh (+34.24%)
Chuck Royce 40,000 sh (-4.08%)
» More
Q2 2014

MDSO Guru Trades in Q2 2014

Frank Sands 4,720,008 sh (New)
George Soros 126,666 sh (New)
Columbia Wanger 1,360,500 sh (+105.36%)
Chuck Royce 40,000 sh (unchged)
Steven Cohen 47,400 sh (unchged)
Jim Simons Sold Out
Ron Baron 230,635 sh (-55.48%)
» More
» Details

Insider Trades

Latest Guru Trades with MDSO

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Frank Sands 2014-06-30 New Buy0.51%$33.98 - $58.27 $ 45.8811%4720008
Ron Baron 2014-06-30 Reduce -55.48%0.06%$33.98 - $58.27 $ 45.8811%230635
George Soros 2014-06-30 New Buy0.04%$33.98 - $58.27 $ 45.8811%126666
Ron Baron 2014-03-31 Add 328.13%0.08%$51.84 - $67.54 $ 45.88-25%518040
Ron Baron 2013-12-31 New Buy0.03%$43.03 - $61.755 $ 45.88-17%121000
Mariko Gordon 2013-12-31 Sold Out 0.02%$43.03 - $61.755 $ 45.88-17%0
Mariko Gordon 2013-09-30 New Buy0.02%$36.86 - $50.41 $ 45.884%3640
Joel Greenblatt 2012-12-31 Sold Out 0.04%$18.69 - $21.43 $ 45.88131%0
Joel Greenblatt 2012-06-30 Reduce -51.69%0.04%$12.28 - $16.34 $ 45.88234%16667
Joel Greenblatt 2012-03-31 Reduce -27.73%0.04%$9.31 - $13.83 $ 45.88344%34499
Joel Greenblatt 2011-09-30 Add 310.24%0.09%$7.27 - $12.24 $ 45.88395%45007
Lee Ainslie 2011-06-30 Sold Out 0.13%$10.7 - $13.06 $ 45.88284%0
Joel Greenblatt 2011-06-30 New Buy0.04%$10.7 - $13.06 $ 45.88284%10971
Premium More recent guru trades are included for Premium Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 384.80
MDSO's P/E(ttm) is ranked higher than
56% of the 1830 Companies
in the Global Software - Application industry.

( Industry Median: 48.90 vs. MDSO: 384.80 )
MDSO' s 10-Year P/E(ttm) Range
Min: 11.44   Max: 384.83
Current: 384.8

11.44
384.83
P/B 10.67
MDSO's P/B is ranked lower than
61% of the 1830 Companies
in the Global Software - Application industry.

( Industry Median: 2.95 vs. MDSO: 10.67 )
MDSO' s 10-Year P/B Range
Min: 2.26   Max: 15.55
Current: 10.67

2.26
15.55
P/S 8.20
MDSO's P/S is ranked lower than
66% of the 1830 Companies
in the Global Software - Application industry.

( Industry Median: 2.37 vs. MDSO: 8.20 )
MDSO' s 10-Year P/S Range
Min: 1.31   Max: 12.62
Current: 8.2

1.31
12.62
PFCF 115.45
MDSO's PFCF is ranked higher than
66% of the 1830 Companies
in the Global Software - Application industry.

( Industry Median: 9999.00 vs. MDSO: 115.45 )
MDSO' s 10-Year PFCF Range
Min: 12.91   Max: 179.68
Current: 115.45

12.91
179.68
EV-to-EBIT 163.19
MDSO's EV-to-EBIT is ranked higher than
60% of the 1830 Companies
in the Global Software - Application industry.

( Industry Median: 34.84 vs. MDSO: 163.19 )
MDSO' s 10-Year EV-to-EBIT Range
Min: 8.8   Max: 381.8
Current: 163.19

8.8
381.8
PEG 83.65
MDSO's PEG is ranked higher than
80% of the 1830 Companies
in the Global Software - Application industry.

( Industry Median: 9999.00 vs. MDSO: 83.65 )
MDSO' s 10-Year PEG Range
Min: 7.91   Max: 208.02
Current: 83.65

7.91
208.02
Shiller P/E 146.96
MDSO's Shiller P/E is ranked higher than
71% of the 1830 Companies
in the Global Software - Application industry.

( Industry Median: 9999.00 vs. MDSO: 146.96 )
MDSO' s 10-Year Shiller P/E Range
Min: 126.29   Max: 6000
Current: 146.96

126.29
6000
Current Ratio 3.58
MDSO's Current Ratio is ranked higher than
83% of the 1308 Companies
in the Global Software - Application industry.

( Industry Median: 2.04 vs. MDSO: 3.58 )
MDSO' s 10-Year Current Ratio Range
Min: 0.44   Max: 5.35
Current: 3.58

0.44
5.35
Quick Ratio 3.58
MDSO's Quick Ratio is ranked higher than
84% of the 1308 Companies
in the Global Software - Application industry.

( Industry Median: 1.91 vs. MDSO: 3.58 )
MDSO' s 10-Year Quick Ratio Range
Min: 0.44   Max: 5.35
Current: 3.58

0.44
5.35

Valuation & Return

vs
industry
vs
history
Price/Tangible Book 11.46
MDSO's Price/Tangible Book is ranked higher than
59% of the 1830 Companies
in the Global Software - Application industry.

( Industry Median: 7.48 vs. MDSO: 11.46 )
MDSO' s 10-Year Price/Tangible Book Range
Min: 3.16   Max: 75.75
Current: 11.46

3.16
75.75
Price/DCF (Projected) 7.28
MDSO's Price/DCF (Projected) is ranked higher than
72% of the 1830 Companies
in the Global Software - Application industry.

( Industry Median: 8.28 vs. MDSO: 7.28 )
MDSO' s 10-Year Price/DCF (Projected) Range
Min: 4.85   Max: 10.1
Current: 7.28

4.85
10.1
Price/Median PS Value 2.34
MDSO's Price/Median PS Value is ranked higher than
50% of the 1830 Companies
in the Global Software - Application industry.

( Industry Median: 1.20 vs. MDSO: 2.34 )
MDSO' s 10-Year Price/Median PS Value Range
Min: 0.38   Max: 3.38
Current: 2.34

0.38
3.38
Price/Graham Number 14.16
MDSO's Price/Graham Number is ranked higher than
66% of the 1830 Companies
in the Global Software - Application industry.

( Industry Median: 10.14 vs. MDSO: 14.16 )
MDSO' s 10-Year Price/Graham Number Range
Min: 0.96   Max: 14.19
Current: 14.16

0.96
14.19
Earnings Yield (Greenblatt) 0.60
MDSO's Earnings Yield (Greenblatt) is ranked lower than
61% of the 1445 Companies
in the Global Software - Application industry.

( Industry Median: 5.60 vs. MDSO: 0.60 )
MDSO' s 10-Year Earnings Yield (Greenblatt) Range
Min: 0.3   Max: 11.3
Current: 0.6

0.3
11.3
Forward Rate of Return (Yacktman) 2.50
MDSO's Forward Rate of Return (Yacktman) is ranked higher than
67% of the 1267 Companies
in the Global Software - Application industry.

( Industry Median: 5.90 vs. MDSO: 2.50 )
MDSO' s 10-Year Forward Rate of Return (Yacktman) Range
Min: 0.5   Max: 21
Current: 2.5

0.5
21

Business Description

Industry: Application Software » Software - Application
Compare: » details
Traded in other countries:2M9.Germany
Medidata Solutions, Inc., was organized as a New York corporation in June 1999 and reincorporated in the State of Delaware in May 2000. The Company provides cloud-based solutions for life sciences that enhance the efficiency of its customers' clinical development processes from concept to conclusion, optimizing their research and development investments. Its solutions allow customers to increase the value of their development programs by more efficiently and effectively designing, planning, and managing key aspects of the clinical trial process, including study and protocol design, trial planning and budgeting, site negotiation, clinical portal, trial management, randomization and trial supply management, clinical data capture and management, safety events capture, medical coding, clinical business analytics, and data flow and interoperability among multiple trial applications. Medidata Rave is a comprehensive solution that integrates electronic data capture, or EDC, with a clinical data management system, or CDMS, in a single solution that replaces traditional paper-based methods of capturing and managing clinical data. Medidata Rave offers a robust, flexible platform enabling sponsors to manage increasingly complex trials. Additional Rave solutions provide efficiencies in other areas of clinical data management, replacing separate activities with integrated, risk-minimizing, resource-saving solutions. Medidata CTMS is a clinical trial management system that offers robust, easy-to-use trial monitoring, administration, and tracking tools. Medidata Insights provides clinical business analytics for more informed development decisions and improved resource allocation, leading to increased operational effectiveness. Medidata Designer, a clinical study and protocol design tool, enables customers to design trial protocols more effectively and automatically configure Medidata Rave and other downstream systems, shortening the planning and set-up phase of the trial process. Medidata Grants Manager enables customers to increase the efficiency of trial budgeting and investigator contracting as well as improve compliance. Medidata CRO Contractor facilitates CRO outsourcing, budgeting and contract negotiation. Medidata Balance is a randomization development and execution application used for randomization and trial supply management, or RTSM, addressing not only the management of the randomization and supplies function, but also the design and implementation of the study. The Company markets and sells its application services through a direct sales force and through relationships with CROs and other strategic partners. The Company competes with firms including Oracle, Perceptive Informatics and other offering products that competes with one or more of its solutions. The use of Company's software products, services and hosted solutions by customers engaged in clinical trials must be done in a manner that is compliant with a complex array of Un
» More Articles for MDSO

Headlines

Articles On GuruFocus.com
Frank Sands Adds 5 New Stocks Aug 14 2014 
Medidata Solutions: Benefit from Growing Cloud Applications with This Stock May 27 2014 
Medidata Solutions : A SAAS Provider For Your Portfolio Mar 23 2014 
Medidata Solutions Inc. (MDSO) Chairman & CEO Tarek Sherif sells 8,667 Shares Mar 08 2011 
Medidata Solutions Inc. (MDSO) Chairman & CEO Tarek Sherif sells 8,000 Shares Mar 03 2011 
Medidata Solutions Inc. (MDSO) Chairman & CEO Tarek Sherif sells 13,667 Shares Feb 07 2011 
Medidata Solutions Inc. (MDSO) Chairman & CEO Tarek Sherif sells 3,000 Shares Feb 03 2011 
Medidata Solutions Inc. (MDSO) Chairman & CEO Tarek Sherif sells 13,667 Shares Jan 10 2011 
Medidata Solutions Inc. (MDSO) Chairman & CEO Tarek Sherif sells 3,000 Shares Jan 05 2011 
Medidata Solutions Inc. (MDSO) Chairman & CEO Tarek Sherif sells 8,998 Shares Dec 08 2010 

More From Other Websites
Medidata to Present at Citi 2014 Global Technology Conference Aug 27 2014
Insider Trading Alert - CHRW, MDSO And XEC Traded By Insiders Aug 26 2014
MEDIDATA SOLUTIONS, INC. Financials Aug 13 2014
MEDIDATA SOLUTIONS, INC. Files SEC form 10-Q, Quarterly Report Aug 07 2014
Top Swing Trade Ideas for Tuesday, August 5: Darden Restaurants, Medidata, More Aug 05 2014
Medidata to Present at Needham Interconnect Conference Aug 04 2014
Medidata to Present at Needham Interconnect Conference Aug 04 2014
Medidata VP of Product Strategy Honored Among PharmaVOICE 100 Most Inspiring People Aug 01 2014
Medidata VP of Product Strategy Honored Among PharmaVOICE 100 Most Inspiring People Aug 01 2014
Medidata Reports Record Second Quarter 2014 Results Jul 29 2014
Q2 2014 MEDIDATA SOLUTIONS INC Earnings Release - Before Market Open Jul 29 2014
MEDIDATA SOLUTIONS, INC. Files SEC form 8-K, Results of Operations and Financial Condition,... Jul 29 2014
Medidata Reports Record Second Quarter 2014 Results Jul 29 2014
Medidata Schedules Second Quarter Earnings Conference Call for July 29, 2014 Jul 15 2014
Medidata Schedules Second Quarter Earnings Conference Call for July 29, 2014 Jul 15 2014
Insider Trading Alert - PANW, MDSO And KR Traded By Insiders Jul 11 2014
MEDIDATA SOLUTIONS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial... Jul 09 2014
MEDIDATA SOLUTIONS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial... Jul 08 2014
Your first trade for Wednesday Jun 18 2014

Personalized Checklist








Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

Add Notes, Comments or Ask Questions

User Comments

No comment yet

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK